REFERENCES
1 Walsh G. Biopharmaceutical benchmarks. Nature biotechnol. In press
2 Pavlou AK, Reichert JM. Recombinant protein therapeutics—success rates, market trends and values to 2010. Nature biotechnol.
2004;22:1513-19.
3 Pavlou A, Belsey, M. The therapeutic antibody market to 2008. Eur. J. Pharm. Biopharm. 2005; 59:389-396.
4
http://www.fda.gov/
5
http://www.emea.eu.int/
6 Walsh G. Biopharmaceuticals: approvals and approval trends in 2004. Biopharm Int.2005;18 (5):58-65.
|